Jenn McNary

Co-Founder and Principal
Canary Advisors

Jenn McNary is the Co-Founder and Principal of Canary Advisors, a boutique patient advocacy consulting firm with a focus on regulatory and access patient engagement.

Accelerated Approval: Reality vs. Expectations (Panel Discussion)
Tuesday, June 13, 2023
9:15 a.m. – 10:15 a.m. CT

VIEW AGENDA

Jenn McNary is a trusted voice in the rare disease community, as a mother, public speaker and fierce advocate. Her work in the rare disease space as a thought leader earned her the Ryan’s Quest Ryan’s Hero award in 2013, and the prestigious 2017 Meyer- Whalley instrument of change award. Formerly as the director of outreach and advocacy at a Massachusetts based non-profit foundation, she was responsible for the organization of the largest FDA advisory committee hearing in history, with over 1000 duchenne advocates, families, clinicians and researchers in attendance.

There are currently only three drugs approved for Duchenne, Exondys51, Vyondys53 and Emflaza, though in various roles, Jenn was involved in the approval process for all three. Jenn has unique experience in the drug development field, as a parent of children enrolled in the clinical trials, an advocate engaging with the regulators and as a patient engagement professional in the life sciences.

Currently, Jenn is the Co-Founder and Principal of Canary Advisors, a boutique patient advocacy consulting firm with a focus on regulatory and access patient engagement. Her other activities include serving as the Founder of One Rare, a non-profit formed to meet the needs of young adults with rare and chronic conditions and raising her children in Massachusetts.

“Doug Long has earned a reputation as one of the foremost ‘go-to’ sources when it comes to the numbers and trends behind this industry. He has built a reputation of synthesizing the latest industry information and forecasting ‘what’s next’ in ways that helps stakeholders to understand what it means for their day-to-day businesses.”

STEVEN C. ANDERSON, IOM, CAE

NACDS President and CEO

Learn more about our Crossroads 2023 Speakers!

Peter D’Alba

Aurelia Chaudhury

Edna Y. Marín Ramos

Sandy Kapur

Jenn McNary

ALL SPEAKERS

The South Carolina Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Continuing education credits will be available to participants who fully attend the program and then complete an online educational activity evaluation. A unique code given at each activity must be provided in the evaluation to receive credit. Grievances regarding the education program must be submitted in writing to the SCPhA ACPE Administrator immediately following the program.